Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,091)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (40)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,065)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,629)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (41)
- (255)
- (159)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,338)
- (25)
- (3)
- (30)
- (14)
- (10)
- (72)
- (13)
- (78)
- (77)
- (34)
- (1)
- (13)
- (1)
- (1,155)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,641)
- (2,890)
- (4)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,317)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (11)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,021)
- (1,863)
- (1)
- (1)
Conjugate
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,860)
Recombinant
- (58)
- (34,768)
Form
- (1)
- (23,073)
- (9,214)
- (29)
- (146)
- (24)
- (35)
Regulatory Status
- (75)
- (30,540)
Showing products from the Recombinant Proteins category.
View All Search Results
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
40,101
results
Invitrogen™ Vaccinia Virus B18R (Carrier-Free) Recombinant Protein, eBioscience™
Recombinant Protein
| Content And Storage | -80°C |
|---|---|
| Purity or Quality Grade | >98% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Liquid |
| pH Range | 7.5 |
| Common Name | Vaccinia Virus B18R |
| Molecular Weight (g/mol) | 48 kDa |
| Gene Symbol | Vaccinia Virus-Encoded Neutralizing Type I Interferon Receptor; Type I IFN inhibitor |
| Endotoxin Concentration | <0.01 ng/μg |
| Sequence | Vaccinia Virus B18R, ammino acids His20-Glu351 (Accession # D01019) with a His-tag |
| Concentration | 0.5 mg/mL |
| Expression System | Insect cells |
| For Use With (Application) | Bioactivity,Functional Assay |
| Source | Vaccinia Virus |
| Protein Subtype | Recombinant |
| Name | Vaccinia Virus B18R (Carrier-Free) |
| Purification Method | Purified |
| Product Type | Protein |
| Biological Activity | Pre-incubation of recombinant IFN-alpha 2 A with 0.1 μg/mL B18R for 1 hour (at RT was found to completely neutralize the activity of 1 ng/mL IFN-alpha 2 a.) |
| Formulation | PBS with no preservative; pH 7.5 |
| Shelf Life | 12 Months |
| Protein Tag | His-tag |
| Species | Bovine,Human,Mouse,Pig,Rabbit,Rat |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | RSPO3 |
| Molecular Weight (g/mol) | 26.9 kDa |
| Gene Symbol | RSPO3 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHPNVSQGCQ GGCATCSDYN GCLSCKPRLF FALERIGMKQ IGVCLSSCPS GYYGTRYPDI NKCTKCKADC DTCFNKNFCT KCKSGFYLHL GKCLDNCPEG LEANNHTMEC VSIVHCEVSE WNPWSPCTKK GKTCGFKRGT ETRVREIIQH PSAKGNLCPP TNETRKCTVQ RKKCQKGERG KKGRERKRKK PNKGESKEAI PDSKSLESSK EIPEQRENKQ QQKKRKVQDK QKSVSVSTVH |
| Expression System | CHO cells |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Name | Human R-Spondin-3 |
| Accession Number | Q9BXY4 |
| Gene Alias | 2810459H04Rik; AW742308; Cabriolet; cristin 1; Cristin1; cristin-1; cysteine-rich and single thrombospondin domain-containing protein 1; hPWTSR; hRspo3; Nucleopondin; protein with TSP type-1 repeat; PWTSR; RGD1563246; Roof plate-specific spondin-3; Rspo3; R-spondin 3; R-spondin 3 homolog; R-spondin 3 homolog (Xenopus laevis); R-spondin 3-like protein; R-spondin-3; Thrombospondin type-1 domain-containing protein 2; thrombospondin, type I, domain 2; thrombospondin, type I, domain containing 2; Thsd2; Unknown (protein for MGC:137973) |
| Biological Activity | R-Spondin-3 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 for this effect is 0.8 -2.0 ug/ml |
| Gene ID (Entrez) | 84870 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CTGF |
| Molecular Weight (g/mol) | 11 kDa |
| Gene Symbol | CCN2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | GKKCIRTPKI SKPIKFELSG CTSMKTYRAK FCGVCTDGRC CTPHRTTTLP VEFKCPDGEV MKKNMMFIKT CACHYNCPGD NDIFESLYYR KMYGDMA |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human CTGF (CCN2) |
| Accession Number | P29279 |
| Gene Alias | 2-Nov; betaIG-M2; CCN family member 2; Ccn2; Cellular communication network factor 2; connective tissue growth factor; connective tissue growth factor precursor; Connective tissue growth factor precursor (CTGF) (FISP-12 protein) (Hypertrophic chondrocyte-specific protein 24); connective tissue growth-related protein; CTGF; CTGF protein; CTGRP; fibroblast inducible secreated protein; fibroblast inducible secreted protein; Fisp12; fisp-12; Hcs24; H-CTGF; hypertrophic chondrocyte-specific gene product 24; hypertrophic chondrocyte-specific protein 24; IBP-8; IGF-binding protein 8; IGFBP8; IGFBP-8; Insulin-like growth factor-binding protein 8; MGC102839; NOV2; Protein FISP-12; similar to connective tissue growth factor precursor |
| Biological Activity | Determined by its ability to stimulate the proliferation of mouse Balb/c 3T3 cells. |
| Gene ID (Entrez) | 1490 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | ICAM-2 |
| Molecular Weight (g/mol) | 48.5 kDa |
| Gene Symbol | ICAM2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SDEKVFEVHV RPKKLAVEPK GSLEVNCSTT CNQPEVGGLE TSLDKILLDE QAQWKHYLVS NISHDTVLQC HFTCSGKQES MNSNVSVYQP PRQVILTLQP TLVAVGKSFT IECRVPTVEP LDSLTLFLFR GNETLHYETF GKAAPAPQEA TATFNSTADR EDGHRNFSCL AVLDLMSRGG NIFHKHSAPK MLEIYEPVSD SQGGPKSCDK THTCPPCPAP ELLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSRDELTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK |
| Expression System | CHO cells |
| For Use With (Application) | Control,Bioactivity |
| Source | CHO cells |
| Name | Human ICAM-2 Fc |
| Accession Number | P13598 |
| Gene Alias | CD102; Icam2; ICAM-2; Intercellular adhesion molecule 2; Ly-60; Lymphocyte function-associated AG-1 counter-receptor; RP23-418O11.10-001 |
| Biological Activity | Determined by its ability to support the adhesion of PMA-stimulated HSB2 cells to plates pre-coated with ICAM-3 Fc. The ED50 for this effect is 1.0-5.0 ug/ml |
| Gene ID (Entrez) | 3384 |
| Formulation | Protein with no preservative |
| Protein Tag | Fc-tag |
| Recombinant | Recombinant |
